Tesla has renamed Full Self-Driving (Supervised) as Tesla Assisted Driving on European websites after German regulators called the old label misleading. The change aligns the marketing more closely with the product's legal status, but it does not grant EU-wide approval or make the driver-assistance system autonomous.
What changed, and what did not
Germany's transport ministry said the system does not take over the entire driving task. It can accelerate, brake and steer, but the driver must remain attentive. Official Czech transport material describes the technology as SAE Level 2, meaning the vehicle can assist with steering and speed while the human remains responsible.
Tesla still uses the Full Self-Driving (Supervised) name in the United States, where the package costs $99 per month. CNBC reported that Tesla had 1.48 million active FSD subscriptions in its second-quarter update. The company did not disclose how many were paid subscriptions rather than free trials, so multiplying the total by the monthly price would overstate recurring revenue.
The approval path remains the catalyst
Reuters reported that an EU-wide vote was delayed from October until at least December 2026, with additional testing in countries including France. Some countries have recognized a provisional Dutch approval, but national recognition is not the same as a final bloc-wide decision.
The rename may reduce one source of regulatory friction because the new label states the system's assisted nature more clearly. It does not resolve safety questions. U.S. regulators continue to examine performance in reduced visibility and possible traffic-law violations. European authorities also need evidence on monitoring, driver behavior and system limits under local road conditions.
Why this matters financially
Tesla's software strategy depends on converting vehicles already on the road into recurring, high-margin subscriptions. European access expands the potential customer base, but paying adoption matters more than the number of vehicles technically eligible. Free trials can increase active users without producing the same economics.
BTI's bottom line
The new name is a compliance concession, not a regulatory victory. Investors should watch the timing and scope of any EU approval, paid conversion rates, trial disclosure and safety conditions. A broader launch could support software revenue, while further delays or restrictions would push that option value farther out.